A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-13
DOI
10.3389/fimmu.2022.956679
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiogenomics in Interventional Oncology
- (2021) Amgad M. Moussa et al. Current Oncology Reports
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
- (2021) Siyuan Dai et al. Journal for ImmunoTherapy of Cancer
- Radiogenomics in Colorectal Cancer
- (2021) Bogdan Badic et al. Cancers
- Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
- (2021) Chirag Krishna et al. CANCER CELL
- Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients
- (2021) Yiliang Meng et al. Journal of Immunology Research
- Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma
- (2021) Kaili Chang et al. Frontiers in Oncology
- Radiomics for Renal Cell Carcinoma: Predicting Outcomes from Immunotherapy and Targeted Therapies—A Narrative Review
- (2021) Kathrine S. Rallis et al. European Urology Focus
- Tumor heterogeneity
- (2021) Dana Pe’er et al. CANCER CELL
- Clinical and therapeutic relevance of cancer-associated fibroblasts
- (2021) Yang Chen et al. Nature Reviews Clinical Oncology
- Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
- (2021) Lewis Au et al. CANCER CELL
- Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma—a systematic review and meta-analysis
- (2020) Stephan Ursprung et al. EUROPEAN RADIOLOGY
- Introduction to Radiomics
- (2020) Marius E Mayerhoefer et al. JOURNAL OF NUCLEAR MEDICINE
- Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature
- (2020) Rodrigo Suarez-Ibarrola et al. Cancers
- Radiomics in medical imaging—“how-to” guide and critical reflection
- (2020) Janita E. van Timmeren et al. Insights into Imaging
- Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
- (2020) Robert J. Motzer et al. NATURE MEDICINE
- Targeting the HIF2–VEGF axis in renal cell carcinoma
- (2020) Toni K. Choueiri et al. NATURE MEDICINE
- Radiomics of Liver Metastases: A Systematic Review
- (2020) Francesco Fiz et al. Cancers
- Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma
- (2020) Rui Peng et al. Cancer Management and Research
- Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma
- (2020) Chao-Liang Xu et al. Frontiers in Genetics
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives
- (2019) William C. Huang et al. JOURNAL OF UROLOGY
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
- (2019) David J. Clark et al. CELL
- Oncometabolites in renal cancer
- (2019) Cissy Yong et al. Nature Reviews Nephrology
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Metabolic reprogramming in clear cell renal cell carcinoma
- (2017) Hiromi I. Wettersten et al. Nature Reviews Nephrology
- Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
- (2016) Johannes Schödel et al. EUROPEAN UROLOGY
- Neoadjuvant Sorafenib Treatment of Clear Cell Renal Cell Carcinoma and Release of Circulating Tumor Fragments
- (2014) Gursah Kats-Ugurlu et al. NEOPLASIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now